2022 Guidance and E.S.G. Considerations
•
A Look Back
FY 2021 Accomplishments
Clinical Distinction
Maintained at least 95% of
all Home Health care centers
achieving 4.0+ Quality of
Patient Care star score
Outperformed industry
on all hospice item set (HIS)
quality metrics
Outstanding Outcomes
for Our Patients
(+)
Amedisys Care Centers and Clinical Team
CLINICAL
DISTINCTION
EMPLOYER OF
CHOICE
OPERATIONAL
EXCELLENCE &
EFFICIENCY
DRIVING
GROWTH
•
Employer of Choice
•
Ended the year with overall
voluntary turnover of
19.4% (FY'21)
While the industry is reporting
record increases in nursing
turnover; in 2021, we reduced
our nursing turnover to
26.8% from 29.5% in 2020,
a 9% YoY reduction
Operational Excellence and
Efficiency
•
.
Grew EBITDA by 10% from
$273.5M in 2020 to $299.6M
in 2021
Expanded consolidated
EBITDA margin 40 bps to
13.6% (FY'21) despite
continuing impacts from
COVID-19
Delivered $189M in cash
flow from operations
Driving Growth
•
•
•
Grew Home Health same
store total admissions
+6% and Hospice same
store total admissions
+2%
Acquired four CONS and VNA
(Home Health in Omaha, NE)
Acquired Contessa Health
(closed in August 2021)
Contessa subsequently
signed new JV partnerships
with Henry Ford Health
Plan and Penn State Health
3View entire presentation